Development and Validation of a UHPLC-MS/MS Method for Ciprofol Detection in Plasma: Application in Clinical Pharmacokinetic Studies
Jiaxi Zhu,1,2,* Ying Cao,2,* Xingan Zhang,2 Bo Xu2 1The First School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, 510515, People’s Republic of China; 2Department of Anesthesiology, General Hospital of Southern Theater Command of PLA, Guangzhou, Gua...
Saved in:
| Main Authors: | Zhu J, Cao Y, Zhang X, Xu B |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-07-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/development-and-validation-of-a-uhplc-msms-method-for-ciprofol-detecti-peer-reviewed-fulltext-article-DDDT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Determination of QLNC-3A6 in canine plasma by UHPLC-MS/MS and its application in pharmacokinetic studies
by: Sumeng Chen, et al.
Published: (2024-12-01) -
Pharmacokinetics, bioavailability, and tissue distribution of MRTX1133 in rats using UHPLC-MS/MS
by: Wei Lu, et al.
Published: (2024-12-01) -
Head-to-Head Comparison of UHPLC-MS/MS and Alinity C for Plasma Analysis of Risperidone and Paliperidone
by: Francisco José Toja-Camba, et al.
Published: (2024-10-01) -
Development and application of a UHPLC-MS/MS method for the simultaneous determination of firmonertinib and its main metabolite AST-5902 in rat plasma: a study on the in vivo drug interaction between firmonertinib and paxlovid
by: Peng-Fei Tang, et al.
Published: (2025-05-01) -
Validation of a method for the quantitative determination of narcotic and psychotropic substances in urine by UHPLC–MS/MS
by: N. B. Savelieva, et al.
Published: (2022-07-01)